Spero Therapeutics Inc (SPRO)

Spero Therapeutics Inc. recorded one insider sale totaling $42,485 over the past ninety days. This transaction involved Esther Rajavelu offloading shares. The company stock price has declined 18.5% recently, while the last earnings report showed a 15.79% beat. No purchase activity occurred during this period.
Ticker: SPRO Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Spero Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.9
Rajavelu Esther See Remarks Executive Director
Transaction date
Sale
Price
241.84
Quantity 5,548 -5.7%
Value US$4,620,207
2.9
Rajavelu Esther See Remarks Officer
Transaction date
Sale
Price
495.73
Quantity 74,789 -2.2%
Value US$900,718
2.9
Rajavelu Esther See Remarks Officer
Transaction date
Sale
Price
231.70
Quantity 98,478 +11.7%
Value US$2,291,416
2.9
Rajavelu Esther See Remarks Officer
Transaction date
Sale
Price
2.36
Quantity 37,101 -3.4%
Value US$87,558
2.3
Keutzer Timothy Chief Operating Officer Officer
Transaction date
Sale
Price
2.36
Quantity 18,652 -2.5%
Value US$44,019
2.3
Keutzer Timothy Chief Operating Officer Officer
Transaction date
Sale
Price
2.24
Quantity 3,471 -0.5%
Value US$7,775
2.3
Keutzer Timothy Chief Operating Officer Officer
Transaction date
Sale
Price
2.14
Quantity 24,224 -3.1%
Value US$51,839
2.3
Keutzer Timothy Chief Operating Officer Officer
Transaction date
Sale
Price
2.20
Quantity 18,891 -2.3%
Value US$41,560
2.9
Rajavelu Esther See Remarks Officer
Transaction date
Sale
Price
2.20
Quantity 18,442 -1.6%
Value US$40,572
2.9
Rajavelu Esther See Remarks Officer
Transaction date
Sale
Price
2.20
Quantity 18,442 -1.6%
Value US$40,572
2.9
Rajavelu Esther See Remarks Officer
Transaction date
Sale
Price
2.37
Quantity 40,270 -4.4%
Value US$95,440
2.4
Mahadevia Ankit Non-Executive Director
Transaction date
Sale
Price
1.97
Quantity 6,572 -0.9%
Value US$12,947
2.3
Keutzer Timothy Chief Operating Officer Officer
Transaction date
Sale
Price
1.97
Quantity 1,695 -0.2%
Value US$3,339
2.3
Keutzer Timothy Chief Operating Officer Officer
Transaction date
Sale
Price
0.78
Quantity 24,920 -3.3%
Value US$19,438
2.3
Keutzer Timothy Chief Operating Officer Officer
Transaction date
Sale
Price
0.78
Quantity 27,643 -3.5%
Value US$21,562
2.3
Keutzer Timothy Chief Operating Officer Officer
Transaction date
Sale
Price
0.78
Quantity 3,974 -0.5%
Value US$3,100
2.9
Rajavelu Esther CFO & CBO Officer
Transaction date
Sale
Price
0.78
Quantity 20,689 -2.8%
Value US$16,137
2.7
Shukla Sath CEO & President Officer
Transaction date
Sale
Price
0.78
Quantity 106,408 -5.8%
Value US$82,998
2.7
Shukla Sath CEO & President Officer
Transaction date
Sale
Price
0.78
Quantity 42,786 -2.3%
Value US$33,373
2.7
Shukla Sath CEO & President Officer
Transaction date
Sale
Price
0.78
Quantity 6,139 -0.3%
Value US$4,788
2.4
Mahadevia Ankit Non-Executive Director
Transaction date
Sale
Price
0.78
Quantity 55,260 -7.4%
Value US$43,103
2.4
Mahadevia Ankit Non-Executive Director
Transaction date
Sale
Price
0.78
Quantity 13,959 -1.8%
Value US$10,888
2.9
Rajavelu Esther CFO & CBO Officer
Transaction date
Sale
Price
1.30
Quantity 17,245 -4.3%
Value US$22,418
2.9
Rajavelu Esther CFO & CBO Officer
Transaction date
Sale
Price
1.31
Quantity 23,351 -5.6%
Value US$30,590
2.3
Keutzer Timothy Chief Operating Officer Officer
Transaction date
Sale
Price
1.35
Quantity 2,213 -0.4%
Value US$2,988
2.4
Mahadevia Ankit Non-Executive Director
Transaction date
Sale
Price
1.35
Quantity 5,912 -0.8%
Value US$7,981
2.7
Shukla Sath CEO & President Officer
Transaction date
Sale
Price
1.35
Quantity 2,757 -0.2%
Value US$3,722
2.7
Shukla Sath CEO and President Officer
Transaction date
Sale
Price
1.31
Quantity 17,641 -1.5%
Value US$23,110
2.7
Shukla Sath CEO and President Officer
Transaction date
Sale
Price
1.32
Quantity 14,800 -1.3%
Value US$19,536
2.7
SATYAVRAT SHUKLA Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.45
Quantity 45,093
Value US$65,466
2.7
Shukla Sath CEO and President Executive Director
Transaction date
Planned sale
Price
1.45
Quantity 45,093 -3.7%
Value US$65,385
1.8
HAMED KAMAL Chief Medical Officer Officer
Transaction date
Sale
Price
1.37
Quantity 28,075 -3.4%
Value US$38,463
2.3
Keutzer Timothy Chief Operating Officer Officer
Transaction date
Sale
Price
1.36
Quantity 30,971 -5.5%
Value US$42,121
2.7
Shukla Sath CEO and President Executive Director
Transaction date
Sale
Price
1.37
Quantity 30,901 -2.5%
Value US$42,334
2.4
Mahadevia Ankit Non-Executive Director
Transaction date
Sale
Price
1.37
Quantity 63,795 -7.9%
Value US$87,399
1.8
JOSEPH TAMARA L Chief Legal Officer Officer
Transaction date
Sale
Price
1.37
Quantity 30,906 -5.5%
Value US$42,341
1.8
HAMED KAMAL Chief Medical Officer Officer
Transaction date
Sale
Price
1.27
Quantity 39,496 -6.4%
Value US$50,160
2.7
Shukla Sath CEO and President Executive Director
Transaction date
Planned sale
Price
1.30
Quantity 4,163 -0.7%
Value US$5,412
2.7
SATYAVRAT SHUKLA Officer Officer
Transaction date
Proposed sale
Price
1.30
Quantity 4,163
Value US$5,412
1.8
JOSEPH TAMARA L Chief Legal Officer Officer
Transaction date
Sale
Price
1.26
Quantity 1,854 -0.6%
Value US$2,336
2.4
Mahadevia Ankit Non-Executive Director
Transaction date
Sale
Price
1.26
Quantity 9,040 -1.1%
Value US$11,390
2.7
Shukla Sath CEO and President Executive Director
Transaction date
Sale
Price
1.26
Quantity 1,854 -0.3%
Value US$2,336
2.3
Keutzer Timothy Chief Development Officer Officer
Transaction date
Sale
Price
1.26
Quantity 1,854 -0.6%
Value US$2,336
2.4
Mahadevia Ankit CEO and President Executive Director
Transaction date
Sale
Price
1.81
Quantity 12,286 -1.5%
Value US$22,238
1.8
JOSEPH TAMARA L Chief Legal Officer Officer
Transaction date
Sale
Price
1.86
Quantity 3,394 -1.0%
Value US$6,313
2.3
Keutzer Timothy Chief Operating Officer Officer
Transaction date
Sale
Price
1.86
Quantity 3,394 -1.0%
Value US$6,313
2.7
Shukla Sath Chief Financial Officer Officer
Transaction date
Planned sale
Price
1.83
Quantity 9,504 -3.0%
Value US$17,372
2.7
Shukla Sath Chief Financial Officer Officer
Transaction date
Planned sale
Price
0.89
Quantity 6,017 -9.7%
Value US$5,378
Larkin Cristina Chief Operating Officer Officer
Transaction date
Planned sale
Price
19.00
Quantity 12,000 -88.9%
Value US$228,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-10 2026-11-09 S Sale

See Remarks

Executive Director
5,548 -5.7%
241.84
US$4,620,207
5,548 -5.7% 241.84 US$4,620,207
2026-05-06 2026-05-04 S Sale

See Remarks

Officer
74,789 -2.2%
495.73
US$900,718
74,789 -2.2% 495.73 US$900,718
2026-02-09 2026-02-06 S Sale

See Remarks

Officer
98,478 +11.7%
231.70
US$2,291,416
98,478 +11.7% 231.70 US$2,291,416
2026-02-09 2026-02-06 S Sale

See Remarks

Officer
37,101 -3.4%
2.36
US$87,558
37,101 -3.4% 2.36 US$87,558
2026-02-09 2026-02-06 S Sale

Chief Operating Officer

Officer
18,652 -2.5%
2.36
US$44,019
18,652 -2.5% 2.36 US$44,019
2026-02-05 2026-02-04 S Sale

Chief Operating Officer

Officer
3,471 -0.5%
2.24
US$7,775
3,471 -0.5% 2.24 US$7,775
2026-02-05 2026-02-03 S Sale

Chief Operating Officer

Officer
24,224 -3.1%
2.14
US$51,839
24,224 -3.1% 2.14 US$51,839
2026-02-05 2026-02-02 S Sale

Chief Operating Officer

Officer
18,891 -2.3%
2.20
US$41,560
18,891 -2.3% 2.20 US$41,560
2026-02-04 2026-02-02 S Sale

See Remarks

Officer
18,442 -1.6%
2.20
US$40,572
18,442 -1.6% 2.20 US$40,572
2026-02-04 2026-02-02 S Sale

See Remarks

Officer
18,442 -1.6%
2.20
US$40,572
18,442 -1.6% 2.20 US$40,572
2025-11-12 2025-11-07 S Sale

See Remarks

Officer
40,270 -4.4%
2.37
US$95,440
40,270 -4.4% 2.37 US$95,440
2025-09-03 2025-08-28 S Sale Non-Executive Director
6,572 -0.9%
1.97
US$12,947
6,572 -0.9% 1.97 US$12,947
2025-09-03 2025-08-28 S Sale

Chief Operating Officer

Officer
1,695 -0.2%
1.97
US$3,339
1,695 -0.2% 1.97 US$3,339
2025-02-05 2025-02-05 S Sale

Chief Operating Officer

Officer
24,920 -3.3%
0.78
US$19,438
24,920 -3.3% 0.78 US$19,438
2025-02-05 2025-02-05 S Sale

Chief Operating Officer

Officer
27,643 -3.5%
0.78
US$21,562
27,643 -3.5% 0.78 US$21,562
2025-02-05 2025-02-05 S Sale

Chief Operating Officer

Officer
3,974 -0.5%
0.78
US$3,100
3,974 -0.5% 0.78 US$3,100
2025-02-05 2025-02-05 S Sale

CFO & CBO

Officer
20,689 -2.8%
0.78
US$16,137
20,689 -2.8% 0.78 US$16,137
2025-02-05 2025-02-05 S Sale

CEO & President

Officer
106,408 -5.8%
0.78
US$82,998
106,408 -5.8% 0.78 US$82,998
2025-02-05 2025-02-05 S Sale

CEO & President

Officer
42,786 -2.3%
0.78
US$33,373
42,786 -2.3% 0.78 US$33,373
2025-02-05 2025-02-05 S Sale

CEO & President

Officer
6,139 -0.3%
0.78
US$4,788
6,139 -0.3% 0.78 US$4,788
2025-02-05 2025-02-05 S Sale Non-Executive Director
55,260 -7.4%
0.78
US$43,103
55,260 -7.4% 0.78 US$43,103
2025-02-05 2025-02-05 S Sale Non-Executive Director
13,959 -1.8%
0.78
US$10,888
13,959 -1.8% 0.78 US$10,888
2024-11-12 2024-11-08 S Sale

CFO & CBO

Officer
17,245 -4.3%
1.30
US$22,418
17,245 -4.3% 1.30 US$22,418
2024-11-12 2024-11-07 S Sale

CFO & CBO

Officer
23,351 -5.6%
1.31
US$30,590
23,351 -5.6% 1.31 US$30,590
2024-08-29 2024-08-27 S Sale

Chief Operating Officer

Officer
2,213 -0.4%
1.35
US$2,988
2,213 -0.4% 1.35 US$2,988
2024-08-29 2024-08-27 S Sale Non-Executive Director
5,912 -0.8%
1.35
US$7,981
5,912 -0.8% 1.35 US$7,981
2024-08-29 2024-08-27 S Sale

CEO & President

Officer
2,757 -0.2%
1.35
US$3,722
2,757 -0.2% 1.35 US$3,722
2024-08-06 2024-08-05 S Sale

CEO and President

Officer
17,641 -1.5%
1.31
US$23,110
17,641 -1.5% 1.31 US$23,110
2024-08-06 2024-08-02 S Sale

CEO and President

Officer
14,800 -1.3%
1.32
US$19,536
14,800 -1.3% 1.32 US$19,536
2024-02-05 2024-02-05 PrS Proposed sale

Officer; Director

Executive Director
45,093
1.45
US$65,466
45,093 1.45 US$65,466
2024-02-05 2024-02-05 PlS Planned sale

CEO and President

Executive Director
45,093 -3.7%
1.45
US$65,385
45,093 -3.7% 1.45 US$65,385
2024-02-05 2024-02-02 S Sale

Chief Medical Officer

Officer
28,075 -3.4%
1.37
US$38,463
28,075 -3.4% 1.37 US$38,463
2024-02-05 2024-02-02 S Sale

Chief Operating Officer

Officer
30,971 -5.5%
1.36
US$42,121
30,971 -5.5% 1.36 US$42,121
2024-02-05 2024-02-02 S Sale

CEO and President

Executive Director
30,901 -2.5%
1.37
US$42,334
30,901 -2.5% 1.37 US$42,334
2024-02-05 2024-02-02 S Sale Non-Executive Director
63,795 -7.9%
1.37
US$87,399
63,795 -7.9% 1.37 US$87,399
2024-02-05 2024-02-02 S Sale

Chief Legal Officer

Officer
30,906 -5.5%
1.37
US$42,341
30,906 -5.5% 1.37 US$42,341
2023-09-15 2023-09-13 S Sale

Chief Medical Officer

Officer
39,496 -6.4%
1.27
US$50,160
39,496 -6.4% 1.27 US$50,160
2023-08-30 2023-08-29 PlS Planned sale

CEO and President

Executive Director
4,163 -0.7%
1.30
US$5,412
4,163 -0.7% 1.30 US$5,412
2023-08-29 2023-08-29 PrS Proposed sale

Officer

Officer
4,163
1.30
US$5,412
4,163 1.30 US$5,412
2023-08-30 2023-08-28 S Sale

Chief Legal Officer

Officer
1,854 -0.6%
1.26
US$2,336
1,854 -0.6% 1.26 US$2,336
2023-08-30 2023-08-28 S Sale Non-Executive Director
9,040 -1.1%
1.26
US$11,390
9,040 -1.1% 1.26 US$11,390
2023-08-30 2023-08-28 S Sale

CEO and President

Executive Director
1,854 -0.3%
1.26
US$2,336
1,854 -0.3% 1.26 US$2,336
2023-08-30 2023-08-28 S Sale

Chief Development Officer

Officer
1,854 -0.6%
1.26
US$2,336
1,854 -0.6% 1.26 US$2,336
2023-02-06 2023-02-03 S Sale

CEO and President

Executive Director
12,286 -1.5%
1.81
US$22,238
12,286 -1.5% 1.81 US$22,238
2023-02-03 2023-02-02 S Sale

Chief Legal Officer

Officer
3,394 -1.0%
1.86
US$6,313
3,394 -1.0% 1.86 US$6,313
2023-02-03 2023-02-02 S Sale

Chief Operating Officer

Officer
3,394 -1.0%
1.86
US$6,313
3,394 -1.0% 1.86 US$6,313
2023-02-03 2023-02-02 PlS Planned sale

Chief Financial Officer

Officer
9,504 -3.0%
1.83
US$17,372
9,504 -3.0% 1.83 US$17,372
2022-09-26 2022-09-22 S Sale Large shareholder
566,284 -14.2%
2.25
US$1,274,309
566,284 -14.2% 2.25 US$1,274,309
2022-09-26 2022-09-22 S Sale Large shareholder
1,335,512 -25.1%
2.25
US$3,005,303
1,335,512 -25.1% 2.25 US$3,005,303
2022-08-30 2022-08-29 PlS Planned sale

Chief Financial Officer

Officer
6,017 -9.7%
0.89
US$5,378
6,017 -9.7% 0.89 US$5,378
2022-04-28 2022-04-26 B Purchase Large shareholder
39,727 +0.8%
5.24
US$207,971
39,727 +0.8% 5.24 US$207,971
2022-03-16 2022-03-14 B Purchase Large shareholder
8,006 +0.2%
7.63
US$61,054
8,006 +0.2% 7.63 US$61,054
2022-03-16 2022-03-14 B Purchase Large shareholder
15,702 +0.3%
7.63
US$119,743
15,702 +0.3% 7.63 US$119,743
2022-03-02 2022-02-28 B Purchase Large shareholder
15,104 +0.3%
9.53
US$143,931
15,104 +0.3% 9.53 US$143,931
2022-03-02 2022-02-28 B Purchase Large shareholder
29,729 +0.6%
9.53
US$283,297
29,729 +0.6% 9.53 US$283,297
2022-02-23 2022-02-18 B Purchase Large shareholder
14,828 +0.3%
9.24
US$137,039
14,828 +0.3% 9.24 US$137,039
2022-02-01 2022-01-31 B Purchase Large shareholder
125,000 +2.5%
11.59
US$1,448,262
125,000 +2.5% 11.59 US$1,448,262
2022-01-26 2022-01-24 B Purchase Large shareholder
1,599 +0.0%
10.89
US$17,418
1,599 +0.0% 10.89 US$17,418
2022-01-20 2022-01-18 B Purchase Large shareholder
48,488 +1.0%
12.41
US$601,964
48,488 +1.0% 12.41 US$601,964
2022-01-12 2022-01-10 B Purchase Large shareholder
8,867 +0.2%
12.93
US$114,609
8,867 +0.2% 12.93 US$114,609
2022-01-03 2021-12-31 B Purchase Large shareholder
125,000 +2.6%
15.75
US$1,969,025
125,000 +2.6% 15.75 US$1,969,025
2022-01-03 2021-12-30 B Purchase Large shareholder
50,000 +1.0%
15.77
US$788,610
50,000 +1.0% 15.77 US$788,610
2022-01-03 2021-12-29 B Purchase Large shareholder
75,493 +1.6%
14.64
US$1,105,263
75,493 +1.6% 14.64 US$1,105,263
2021-11-02 2021-10-29 B Purchase Large shareholder
150,000 +3.3%
17.53
US$2,630,175
150,000 +3.3% 17.53 US$2,630,175
2021-10-04 2021-09-30 B Purchase Large shareholder
134,543 +3.0%
18.65
US$2,509,173
134,543 +3.0% 18.65 US$2,509,173
2021-09-01 2021-08-31 B Purchase Large shareholder
48,645 +1.1%
18.93
US$920,660
48,645 +1.1% 18.93 US$920,660
2021-09-01 2021-08-30 B Purchase Large shareholder
44,042 +1.0%
17.87
US$786,859
44,042 +1.0% 17.87 US$786,859
2021-02-10 2021-02-08 S Sale Large shareholder
3,000 -0.1%
21.74
US$65,215
3,000 -0.1% 21.74 US$65,215
2021-02-04 2021-02-04 S Sale Large shareholder
34,144 -0.9%
18.99
US$648,255
34,144 -0.9% 18.99 US$648,255
2021-02-04 2021-02-03 S Sale Large shareholder
29,354 -0.8%
18.98
US$557,101
29,354 -0.8% 18.98 US$557,101
2021-02-04 2021-02-02 S Sale Large shareholder
22,841 -0.6%
18.99
US$433,771
22,841 -0.6% 18.99 US$433,771
2021-02-04 2021-02-01 S Sale Large shareholder
13,661 -0.3%
19.24
US$262,861
13,661 -0.3% 19.24 US$262,861
2020-12-18 2020-12-17 S Sale Large shareholder
250,000 -6.0%
18.81
US$4,703,225
250,000 -6.0% 18.81 US$4,703,225
2020-12-18 2020-12-16 PlS Planned sale

Chief Operating Officer

Officer
12,000 -88.9%
19.00
US$228,000
12,000 -88.9% 19.00 US$228,000
2020-12-18 2020-12-16 S Sale Large shareholder
14,933 -0.4%
18.62
US$278,035
14,933 -0.4% 18.62 US$278,035

See older Spero Therapeutics Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Spero Therapeutics Inc history with Plus

Billed monthly · Cancel anytime